menu search

Omega therapeutics to participate in two upcoming investor conferences

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pio...

September 21, 2023, 4:00 pm

Europe expects to decide on novavax's covid vaccine in october

European medicines Agency director Emer Cooke said on Thursday the agency expects to make a decision on...

September 21, 2023, 9:48 am

Onkure therapeutics appoints ann howell, pharm.d., as vice president of regulatory affairs

BOULDER, Colo., Sept. 20, 2023 (GLOBE NEWSWIRE) — OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next gener...

September 20, 2023, 1:41 pm

Veru to participate in fireside chat at the 2023 cantor fitzgerald global healthcare conference on september 28th, 2023

MIAMI, FL, Sept. 20, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel <...

September 20, 2023, 12:30 pm

Newamsterdam pharma to present at 2023 cantor fitzgerald global healthcare conference

NAARDEN, The Netherlands and MIAMI, Sept. 20, 2023 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam Pharma” or ...

September 20, 2023, 8:00 am

Ovid therapeutics to present at the 2023 cantor fitzgerald global healthcare conference

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing ...

September 20, 2023, 7:30 am

Genflow biosciences primed and ready for phase i/ii trial after regulatory sign-off

Genflow Biosciences PLC (LSE:GENF, OTC:GENFF) said it has received encouraging advice from Belgium's Federal Agency for ...

September 20, 2023, 3:24 am

Acrivon therapeutics to highlight its acr-368 oncosignature test, used in ongoing phase 2 study to treat patients based on predicted sensitivity to monotherapy with its chk1/2 inhibitor acr-368, at th

WATERTOWN, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clini...

September 19, 2023, 8:32 pm

2 cutting-edge gene-editing stocks that you don't want to miss

Gene-editing therapies are among the most powerful medicines to ever exist. Wave Life Sciences is takin...

September 19, 2023, 9:37 am

Annexon biosciences to participate in the 2023 cantor global healthcare conference

BRISBANE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class o...

September 19, 2023, 6:30 am

Vigil neuroscience: interesting early data, wait for phase 2

Vigil Neuroscience is developing medicines for neurodegenerative diseases by restoring microglial funct...

September 18, 2023, 2:38 pm

Cellectar biosciences receives european medicines agency priority medicines (prime) designation for iopofosine for waldenstrom’s macroglobulinemia

The EMA’s PRIME status is granted to drug candidates that may offer a major therapeutic advantage over existing treatments, or benefit patients with...

September 18, 2023, 12:40 pm

Verve expands leadership team with appointment of frederick t. fiedorek, m.d., as chief medical officer

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardio...

September 18, 2023, 10:30 am

Vertex (vrtx) gets positive chmp opinion for kaftrio expanded use

Vertex's (VRTX) Kaftrio gets a positive opinion from the European medicines Agency's Committee for Medi...

September 18, 2023, 9:02 am

Catalyst pharmaceuticals to participate at the 2023 cantor global healthcare conference

CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutica...

September 18, 2023, 8:03 am

Triana biomedicines to present at ubs biotechnology private company virtual symposium

LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a t...

September 18, 2023, 7:30 am

Here are 15 new reasons to be bullish about moderna stock

Moderna's coronavirus vaccine revenue is tanking, and it could continue to fall. However, the company has plenty of activity ongoing in the pipeline, ...

September 18, 2023, 5:15 am

Eu recommends approval of astrazeneca and daiichi's drug for a type of lung cancer

AstraZeneca said on Friday the European medicines Agency's human ...

September 15, 2023, 10:17 am

Ptc therapeutics slumps on eu snub for dmd drug

PTC Therapeutics (NASDAQ:PTCT) stock sank in Friday premarket trading after the European medicines Agen...

September 15, 2023, 9:18 am

Eu regulator recommends to stop sale of gsk's blood cancer drug

The European medicines Agency's human medicines committe...

September 15, 2023, 8:56 am


Search within

Pages Search Results: